After years of patent protection, biosimilars for Humira are set to enter the US market in 2023. The arrival of these drugs has been widely anticipated throughout the healthcare industry. Yet, their ...

Arizona employers face a reality: health care costs continue to rise driven primarily by pharmaceutical innovation that is ...

In this week’s edition of InnovationRx, we look at AbbVie’s new megadeal, an agentic AI startup saving Medicare $2 million a ...

Medicare Part D helps roughly 54.8 million of older Americans, nearly 80% of all Medicare enrollees, afford prescription drugs, according to KFF. But rules on what's covered are always changing. Even ...

Many mail-order pharmacy customers feel trapped in a system that has left them with crushed pills, damaged vials and lifesaving drugs exposed to extreme weather. Bianca Bagnarelli / for NBC News ...

While dealmaking and investment dollars may be flowing across biopharma once again, acute challenges tied to policy, pricing and more continue to dog the industry, even as pipelines bring massive ...

The V.I. Department of Licensing and Consumer Affairs has filed a major lawsuit against the country’s largest pharmacy benefit managers and related group purchasing organizations, accusing them of ...

More than half of patients with treatment-resistant hidradenitis suppurativa achieved a 55% improvement in their disease after initiating golimumab, a tumor necrosis factor inhibitor, according to a ...